Report Detail
Global iPSC-Derived Natural Killer Cells Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4724843 |
- 03 August, 2026 |
- Global |
- 93 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global iPSC-Derived Natural Killer Cells market size was valued at US$ 170 million in 2025 and is forecast to a readjusted size of US$ 1106 million by 2032 with a CAGR of 30.3% during review period.
iPSC-Derived Natural Killer (NK) Cells refer to NK-like immune effector cells generated from induced pluripotent stem cells (iPSCs) through sequential processes including hematopoietic differentiation, NK cell maturation, expansion, purification, and quality control. These cells can be applied in cancer immunotherapy, B-cell depletion research for autoimmune diseases, infectious disease modeling, and cell therapy manufacturing process development. Key advantages include a standardized cell source, strong batch-to-batch consistency, and high amenability to multi-gene engineering at the iPSC stage, such as CAR insertion, CD16 enhancement, IL-15 expression, and immune-evasion modifications. These cells also support cryopreserved off-the-shelf production. The product category is currently mainly positioned in research-use products, CDMO process platforms, and clinical-stage therapeutic candidates. The overall gross margin is approximately 60%.
The evolution of cancer immunotherapy from autologous CAR-T toward allogeneic, off-the-shelf, and repeat-dose cell therapies is driving iPSC-derived NK cells to become a key next-generation modality. Their core value lies in enabling scalable production from a single master cell bank, thereby reducing donor variability and manufacturing scheduling constraints. In addition, iPSC-derived NK cells can be combined with monoclonal antibodies, bispecific or multispecific NK cell engagers, CAR constructs, and other immune-modulating strategies, enabling applications across hematologic malignancies, solid tumors, and B-cell–mediated autoimmune diseases.
Competitive dynamics are shifting from basic NK cell generation toward advanced cell engineering design, GMP-scale manufacturing, post-thaw functional activity, and batch consistency control. Leading companies typically introduce multi-gene engineering at the iPSC stage, followed by closed-system suspension culture, automated differentiation processes, and standardized quality control to improve manufacturability. In the near term, commercial value is concentrated in clinical-grade cell banks, process development services, CDMO manufacturing, and clinical trial supply. Long-term success depends on demonstrating durable efficacy, safety, and improved tumor infiltration capability, particularly in solid tumor indications.
North America remains the dominant region for clinical translation and capital investment, while Japan, Australia, and China are advancing rapidly in iPSC cell banking, regulatory exploration, and domestic clinical programs. Key uncertainties include long-term safety, residual undifferentiated iPSC control, immune rejection risk, scalability costs, and regulatory approval pathways. If engineering strategies and manufacturing economics continue to improve, iPSC-derived NK cells are expected to establish a differentiated position within the allogeneic cell therapy landscape.
Report Scope
This report is a detailed and comprehensive analysis for global iPSC-Derived Natural Killer Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC-Derived Natural Killer Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Natural Killer Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Natural Killer Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Natural Killer Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for iPSC-Derived Natural Killer Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global iPSC-Derived Natural Killer Cells market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fate Therapeutics, Century Therapeutics, Cartherics, Nuwacell Biotech, HebeCell, Healios, Cytovia Therapeutics, Shoreline Biosciences, Applied StemCell, Cellistic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
iPSC-Derived Natural Killer Cells market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Non-Engineered iPSC-Derived NK Cells
CAR-Engineered iPSC-Derived NK Cells
CD16-Enhanced iPSC-Derived NK Cells
Immune-Evasive iPSC-Derived NK Cells
Multi-Functional iPSC-Derived NK Cells
Market segment by Cell Source Strategy
Healthy Donor iPSC Line
GMP Master iPSC Bank
Gene-Edited Universal iPSC Line
HLA-Matched iPSC Bank
Patient-Specific iPSC Line
Market segment by Therapeutic Indication
Hematologic Malignancies
Solid Tumors
Autoimmune Diseases
Infectious Diseases
Inflammation and Tissue Repair
Other Research Uses
Market segment by Development and Delivery Format
Research-Use Cell Product
Preclinical Candidate
Clinical-Grade Drug Product
CDMO Manufacturing Service
Cell Bank and Starting Material
Market segment by Application
Cancer Immunotherapy
Autoimmune Disease Therapy
Infectious Disease Research
Drug Screening and Mechanism Studies
Cell Therapy Process Development
Other Applications
Major players covered
Fate Therapeutics
Century Therapeutics
Cartherics
Nuwacell Biotech
HebeCell
Healios
Cytovia Therapeutics
Shoreline Biosciences
Applied StemCell
Cellistic
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe iPSC-Derived Natural Killer Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of iPSC-Derived Natural Killer Cells, with price, sales quantity, revenue, and global market share of iPSC-Derived Natural Killer Cells from 2021 to 2026.
Chapter 3, the iPSC-Derived Natural Killer Cells competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the iPSC-Derived Natural Killer Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and iPSC-Derived Natural Killer Cells market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of iPSC-Derived Natural Killer Cells.
Chapter 14 and 15, to describe iPSC-Derived Natural Killer Cells sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global iPSC-Derived Natural Killer Cells Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Non-Engineered iPSC-Derived NK Cells
- 1.3.3 CAR-Engineered iPSC-Derived NK Cells
- 1.3.4 CD16-Enhanced iPSC-Derived NK Cells
- 1.3.5 Immune-Evasive iPSC-Derived NK Cells
- 1.3.6 Multi-Functional iPSC-Derived NK Cells
- 1.4 Market Analysis by Cell Source Strategy
- 1.4.1 Overview: Global iPSC-Derived Natural Killer Cells Consumption Value by Cell Source Strategy: 2021 Versus 2025 Versus 2032
- 1.4.2 Healthy Donor iPSC Line
- 1.4.3 GMP Master iPSC Bank
- 1.4.4 Gene-Edited Universal iPSC Line
- 1.4.5 HLA-Matched iPSC Bank
- 1.4.6 Patient-Specific iPSC Line
- 1.5 Market Analysis by Therapeutic Indication
- 1.5.1 Overview: Global iPSC-Derived Natural Killer Cells Consumption Value by Therapeutic Indication: 2021 Versus 2025 Versus 2032
- 1.5.2 Hematologic Malignancies
- 1.5.3 Solid Tumors
- 1.5.4 Autoimmune Diseases
- 1.5.5 Infectious Diseases
- 1.5.6 Inflammation and Tissue Repair
- 1.5.7 Other Research Uses
- 1.6 Market Analysis by Development and Delivery Format
- 1.6.1 Overview: Global iPSC-Derived Natural Killer Cells Consumption Value by Development and Delivery Format: 2021 Versus 2025 Versus 2032
- 1.6.2 Research-Use Cell Product
- 1.6.3 Preclinical Candidate
- 1.6.4 Clinical-Grade Drug Product
- 1.6.5 CDMO Manufacturing Service
- 1.6.6 Cell Bank and Starting Material
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global iPSC-Derived Natural Killer Cells Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Cancer Immunotherapy
- 1.7.3 Autoimmune Disease Therapy
- 1.7.4 Infectious Disease Research
- 1.7.5 Drug Screening and Mechanism Studies
- 1.7.6 Cell Therapy Process Development
- 1.7.7 Other Applications
- 1.8 Global iPSC-Derived Natural Killer Cells Market Size & Forecast
- 1.8.1 Global iPSC-Derived Natural Killer Cells Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global iPSC-Derived Natural Killer Cells Sales Quantity (2021-2032)
- 1.8.3 Global iPSC-Derived Natural Killer Cells Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Fate Therapeutics
- 2.1.1 Fate Therapeutics Details
- 2.1.2 Fate Therapeutics Major Business
- 2.1.3 Fate Therapeutics iPSC-Derived Natural Killer Cells Product and Services
- 2.1.4 Fate Therapeutics iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Fate Therapeutics Recent Developments/Updates
- 2.2 Century Therapeutics
- 2.2.1 Century Therapeutics Details
- 2.2.2 Century Therapeutics Major Business
- 2.2.3 Century Therapeutics iPSC-Derived Natural Killer Cells Product and Services
- 2.2.4 Century Therapeutics iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Century Therapeutics Recent Developments/Updates
- 2.3 Cartherics
- 2.3.1 Cartherics Details
- 2.3.2 Cartherics Major Business
- 2.3.3 Cartherics iPSC-Derived Natural Killer Cells Product and Services
- 2.3.4 Cartherics iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Cartherics Recent Developments/Updates
- 2.4 Nuwacell Biotech
- 2.4.1 Nuwacell Biotech Details
- 2.4.2 Nuwacell Biotech Major Business
- 2.4.3 Nuwacell Biotech iPSC-Derived Natural Killer Cells Product and Services
- 2.4.4 Nuwacell Biotech iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Nuwacell Biotech Recent Developments/Updates
- 2.5 HebeCell
- 2.5.1 HebeCell Details
- 2.5.2 HebeCell Major Business
- 2.5.3 HebeCell iPSC-Derived Natural Killer Cells Product and Services
- 2.5.4 HebeCell iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 HebeCell Recent Developments/Updates
- 2.6 Healios
- 2.6.1 Healios Details
- 2.6.2 Healios Major Business
- 2.6.3 Healios iPSC-Derived Natural Killer Cells Product and Services
- 2.6.4 Healios iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Healios Recent Developments/Updates
- 2.7 Cytovia Therapeutics
- 2.7.1 Cytovia Therapeutics Details
- 2.7.2 Cytovia Therapeutics Major Business
- 2.7.3 Cytovia Therapeutics iPSC-Derived Natural Killer Cells Product and Services
- 2.7.4 Cytovia Therapeutics iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Cytovia Therapeutics Recent Developments/Updates
- 2.8 Shoreline Biosciences
- 2.8.1 Shoreline Biosciences Details
- 2.8.2 Shoreline Biosciences Major Business
- 2.8.3 Shoreline Biosciences iPSC-Derived Natural Killer Cells Product and Services
- 2.8.4 Shoreline Biosciences iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Shoreline Biosciences Recent Developments/Updates
- 2.9 Applied StemCell
- 2.9.1 Applied StemCell Details
- 2.9.2 Applied StemCell Major Business
- 2.9.3 Applied StemCell iPSC-Derived Natural Killer Cells Product and Services
- 2.9.4 Applied StemCell iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Applied StemCell Recent Developments/Updates
- 2.10 Cellistic
- 2.10.1 Cellistic Details
- 2.10.2 Cellistic Major Business
- 2.10.3 Cellistic iPSC-Derived Natural Killer Cells Product and Services
- 2.10.4 Cellistic iPSC-Derived Natural Killer Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Cellistic Recent Developments/Updates
3 Competitive Environment: iPSC-Derived Natural Killer Cells by Manufacturer
- 3.1 Global iPSC-Derived Natural Killer Cells Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global iPSC-Derived Natural Killer Cells Revenue by Manufacturer (2021-2026)
- 3.3 Global iPSC-Derived Natural Killer Cells Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of iPSC-Derived Natural Killer Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 iPSC-Derived Natural Killer Cells Manufacturer Market Share in 2025
- 3.4.3 Top 6 iPSC-Derived Natural Killer Cells Manufacturer Market Share in 2025
- 3.5 iPSC-Derived Natural Killer Cells Market: Overall Company Footprint Analysis
- 3.5.1 iPSC-Derived Natural Killer Cells Market: Region Footprint
- 3.5.2 iPSC-Derived Natural Killer Cells Market: Company Product Type Footprint
- 3.5.3 iPSC-Derived Natural Killer Cells Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global iPSC-Derived Natural Killer Cells Market Size by Region
- 4.1.1 Global iPSC-Derived Natural Killer Cells Sales Quantity by Region (2021-2032)
- 4.1.2 Global iPSC-Derived Natural Killer Cells Consumption Value by Region (2021-2032)
- 4.1.3 Global iPSC-Derived Natural Killer Cells Average Price by Region (2021-2032)
- 4.2 North America iPSC-Derived Natural Killer Cells Consumption Value (2021-2032)
- 4.3 Europe iPSC-Derived Natural Killer Cells Consumption Value (2021-2032)
- 4.4 Asia-Pacific iPSC-Derived Natural Killer Cells Consumption Value (2021-2032)
- 4.5 South America iPSC-Derived Natural Killer Cells Consumption Value (2021-2032)
- 4.6 Middle East & Africa iPSC-Derived Natural Killer Cells Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global iPSC-Derived Natural Killer Cells Sales Quantity by Type (2021-2032)
- 5.2 Global iPSC-Derived Natural Killer Cells Consumption Value by Type (2021-2032)
- 5.3 Global iPSC-Derived Natural Killer Cells Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global iPSC-Derived Natural Killer Cells Sales Quantity by Application (2021-2032)
- 6.2 Global iPSC-Derived Natural Killer Cells Consumption Value by Application (2021-2032)
- 6.3 Global iPSC-Derived Natural Killer Cells Average Price by Application (2021-2032)
7 North America
- 7.1 North America iPSC-Derived Natural Killer Cells Sales Quantity by Type (2021-2032)
- 7.2 North America iPSC-Derived Natural Killer Cells Sales Quantity by Application (2021-2032)
- 7.3 North America iPSC-Derived Natural Killer Cells Market Size by Country
- 7.3.1 North America iPSC-Derived Natural Killer Cells Sales Quantity by Country (2021-2032)
- 7.3.2 North America iPSC-Derived Natural Killer Cells Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe iPSC-Derived Natural Killer Cells Sales Quantity by Type (2021-2032)
- 8.2 Europe iPSC-Derived Natural Killer Cells Sales Quantity by Application (2021-2032)
- 8.3 Europe iPSC-Derived Natural Killer Cells Market Size by Country
- 8.3.1 Europe iPSC-Derived Natural Killer Cells Sales Quantity by Country (2021-2032)
- 8.3.2 Europe iPSC-Derived Natural Killer Cells Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific iPSC-Derived Natural Killer Cells Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific iPSC-Derived Natural Killer Cells Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific iPSC-Derived Natural Killer Cells Market Size by Region
- 9.3.1 Asia-Pacific iPSC-Derived Natural Killer Cells Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific iPSC-Derived Natural Killer Cells Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America iPSC-Derived Natural Killer Cells Sales Quantity by Type (2021-2032)
- 10.2 South America iPSC-Derived Natural Killer Cells Sales Quantity by Application (2021-2032)
- 10.3 South America iPSC-Derived Natural Killer Cells Market Size by Country
- 10.3.1 South America iPSC-Derived Natural Killer Cells Sales Quantity by Country (2021-2032)
- 10.3.2 South America iPSC-Derived Natural Killer Cells Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa iPSC-Derived Natural Killer Cells Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa iPSC-Derived Natural Killer Cells Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa iPSC-Derived Natural Killer Cells Market Size by Country
- 11.3.1 Middle East & Africa iPSC-Derived Natural Killer Cells Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa iPSC-Derived Natural Killer Cells Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 iPSC-Derived Natural Killer Cells Market Drivers
- 12.2 iPSC-Derived Natural Killer Cells Market Restraints
- 12.3 iPSC-Derived Natural Killer Cells Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of iPSC-Derived Natural Killer Cells and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of iPSC-Derived Natural Killer Cells
- 13.3 iPSC-Derived Natural Killer Cells Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 iPSC-Derived Natural Killer Cells Typical Distributors
- 14.3 iPSC-Derived Natural Killer Cells Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on iPSC-Derived Natural Killer Cells. Industry analysis & Market Report on iPSC-Derived Natural Killer Cells is a syndicated market report, published as Global iPSC-Derived Natural Killer Cells Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of iPSC-Derived Natural Killer Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
